)
Curis (CRIS) investor relations material
Curis Proxy filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Annual meeting scheduled for May 19, 2026, to be held virtually, with voting on five key proposals including director elections, executive compensation, auditor ratification, share authorization increase, and potential adjournment.
Record date for voting is March 23, 2026, with 39,978,693 shares outstanding and each share entitled to one vote.
Proxy materials are available online and by mail, and multiple voting methods are provided: internet, phone, mail, or during the virtual meeting.
Voting matters and shareholder proposals
Proposal 1: Election of two Class III directors for a three-year term.
Proposal 2: Advisory (non-binding) vote on executive compensation (say-on-pay).
Proposal 3: Ratification of PricewaterhouseCoopers LLP as independent auditor for 2026.
Proposal 4: Amendment to increase authorized shares of common stock from 283,757,150 to 567,514,300.
Proposal 5: Approval to adjourn the meeting if more time is needed to solicit votes for Proposal 4.
Board recommends voting FOR all proposals.
Board of directors and corporate governance
Board is classified into three classes with staggered three-year terms; nominees for Class III are Martyn D. Greenacre and Kenneth I. Kaitin, Ph.D.
Majority of directors are independent per Nasdaq standards; all committee members are independent.
Board leadership is separated between CEO and Chairman roles.
Board committees: Audit, Compensation, and Nominating & Corporate Governance, each with defined charters and responsibilities.
Directors are expected to attend annual meetings and participate in ongoing education.
- Emavusertib delivers deep, durable responses in blood cancers and advances toward registrational trials.CRIS
Corporate presentation1 Apr 2026 - Q4 2025 net income surged on Erivedge sale; PCNSL and CLL studies drive future growth.CRIS
Q4 202520 Mar 2026 - Shareholders to vote on share increase, PIPE-related issuances, and a new equity incentive plan.CRIS
Proxy Filing19 Feb 2026 - Registers 107.7M shares for resale by PIPE investors; no proceeds to company; clinical-stage biotech.CRIS
Registration Filing13 Feb 2026 - Shareholders to vote on major share increase, PIPE-related issuances, and a new incentive plan.CRIS
Proxy Filing9 Feb 2026 - Emavusertib gains EU ODD as Q2 net loss hits $11.8M; cash runway extends into Q1 2025.CRIS
Q2 20242 Feb 2026 - Emavusertib delivers strong early results in NHL and AML, with expansion into solid tumors underway.CRIS
H.C. Wainwright 26th Annual Global Investment Conference 202420 Jan 2026 - Promising IRAK4 inhibitor data in AML and NHL drive pivotal trial plans and partnership interest.CRIS
2024 Cantor Fitzgerald Global Healthcare Conference20 Jan 2026 - Q3 net loss narrowed, emavusertib data positive, but cash only funds operations into mid-2025.CRIS
Q3 202414 Jan 2026
Next Curis earnings date
Next Curis earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
Frequently asked questions
Explore our global coverage